Innovation and our Ethical Responsibility

We are focused on innovation, which drives our unwavering commitment to research and development as the path to tomorrow’s breakthrough products. As a leading animal health company, we are committed to bringing the latest technologies to our research efforts and are focused on advancing veterinary medicine through solutions in key therapeutic areas.

Our leading scientific advances, treatments and solutions require the industry’s foremost researchers and state-of-the-art facilities in the world, which are committed to advancing veterinary medicine through novel solutions in key therapeutic areas.

Our R&D efforts include technologies from our acquisitions and investments. These businesses are critical to our innovation efforts:

  • Technology Labs is responsible for product delivery, it leads technology development from identification to monitoring in every space.
  • Data Labs enhances the use of data collection with scale and complexity for customers and enables new services and partnerships with others in the eco-system.
  • Technological Discovery helps shape our discovery efforts by pursuing emerging technologies with startups.

As with our company’s human health pharmaceuticals and vaccines, we test our investigative animal health pharmaceuticals and vaccines vigorously for safety, quality and efficacy before submitting them for approval. In addition, when used in food-producing animals, our submissions to regulatory agencies include rigorous human food safety testing as well as user safety and environmental safety assessments.

We support global harmonization of the regulatory process for veterinary medicinal products through participation in and dialogue with the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) and the Codex Alimentarius Commission.